electroCore (NASDAQ:ECOR) Rating Increased to Strong-Buy at Brookline Capital Management

Brookline Capital Management upgraded shares of electroCore (NASDAQ:ECOR) to a strong-buy rating in a report issued on Tuesday morning,Zacks.com reports.

Several other research analysts also recently commented on ECOR. Wall Street Zen upgraded electroCore from a “sell” rating to a “hold” rating in a research note on Saturday, November 8th. Weiss Ratings restated a “sell (d-)” rating on shares of electroCore in a research note on Monday, December 29th. Zacks Research cut shares of electroCore from a “hold” rating to a “strong sell” rating in a research report on Wednesday, January 28th. Finally, HC Wainwright decreased their price objective on shares of electroCore from $25.00 to $18.00 and set a “buy” rating on the stock in a report on Monday, January 26th. One research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $22.00.

electroCore Price Performance

electroCore stock opened at $5.55 on Tuesday. The company’s 50-day moving average is $5.58 and its 200-day moving average is $5.45. The firm has a market capitalization of $44.40 million, a PE ratio of -3.25 and a beta of 0.48. electroCore has a fifty-two week low of $4.16 and a fifty-two week high of $19.49.

electroCore (NASDAQ:ECOR) last posted its quarterly earnings results on Wednesday, November 5th. The company reported ($0.40) EPS for the quarter, missing analysts’ consensus estimates of ($0.33) by ($0.07). The business had revenue of $8.69 million for the quarter, compared to the consensus estimate of $7.84 million. electroCore had a negative return on equity of 447.87% and a negative net margin of 47.46%. As a group, analysts expect that electroCore will post -1.49 EPS for the current year.

Hedge Funds Weigh In On electroCore

Institutional investors and hedge funds have recently modified their holdings of the business. FNY Investment Advisers LLC bought a new position in electroCore during the fourth quarter worth about $82,000. Two Sigma Investments LP grew its position in shares of electroCore by 20.8% during the 3rd quarter. Two Sigma Investments LP now owns 24,603 shares of the company’s stock worth $122,000 after purchasing an additional 4,231 shares in the last quarter. Cubist Systematic Strategies LLC acquired a new position in shares of electroCore during the 1st quarter worth approximately $153,000. Jaffetilchin Investment Partners LLC increased its holdings in shares of electroCore by 26.7% during the second quarter. Jaffetilchin Investment Partners LLC now owns 41,783 shares of the company’s stock worth $221,000 after purchasing an additional 8,800 shares during the period. Finally, Jane Street Group LLC raised its position in shares of electroCore by 114.4% in the first quarter. Jane Street Group LLC now owns 36,726 shares of the company’s stock valued at $246,000 after buying an additional 19,599 shares in the last quarter. 26.74% of the stock is currently owned by institutional investors and hedge funds.

About electroCore

electroCore, Inc is a commercial-stage bioelectronic medicine company headquartered in Rockaway, New Jersey. The company specializes in the development and commercialization of non-invasive vagus nerve stimulation (nVNS) therapies designed to address a variety of neurological and inflammatory conditions. Established in 2006, electroCore has focused its efforts on translating neuromodulation science into a compact, patient-administered treatment device.

The company’s lead product, gammaCore®, is a handheld, battery-powered device that delivers nVNS through the skin to the cervical branch of the vagus nerve.